DIA will host the first ‘IT Life Sciences Summit 2012: Technology Enabled Pharmaceutical Business Transformation’ in Mumbai on September 6-7, 2012. Michael Davies, Vice President, Global Sales, Oracle Health Sciences will be the Guest of Honour at the summit. Anil Raghavan, Managing Director, Quintiles India and Sairamkumar J, Global Delivery Head, Life Sciences, Cognizant will be the keynote speakers at this conference. The two-day summit will see keynote speakers set the stage for technology, contract research, pharmaceutical, biotechnology and medical device organisations.
| Guest of Honour | Keynote Speakers | |
| Michael Davies, PhD, VP Global Sales, Oracle Health Sciences |
Anil Raghavan, Mng. Director, Quintiles India |
Sairamkumar J Global Delivery Head, Life Sciences Cognizant |
The summit will provide an ideal platform for the life sciences industry, regulators, IT and IT-enabled services industry to converge and consider IT intervention for enhancing competiveness; reducing costs and bringing affordable medicines to market.
Professions from clinical operations, regulatory affairs, data management, drug safety and pharmacovigilance, manufacturing, finance, sales and marketing, research and development life science companies, IT software, hardware and services organisations are expected to attend this summit.
| Programme Advisor |
Global Management Consulting Practice Leader Life Sciences Infosys Ltd. |
Participants will have an opportunity to gain knowledge about the latest developments, case studies and solutions from life science industry experts. Sessions will feature expert presentations on the latest trends and technology advances that are reshaping the life sciences industry. Sessions will be segmented into Pre Clinical and Discovery, Clinical Development, Manufacturing, Commercializ-ation, Regulatory and Quality. There will be special sessions on Social Media in Life Sciences, Emerging Markets and Future Technologies.
A panel discussion on thought provoking topics has been scheduled on both the days. Attendees will have the opportunity to meet with life sciences organisations and technology companies to build collaborative relationships with peers, thought leaders and current and future vendor and partners.
Globally, pharmaceutical companies are faced with drugs coming off patent, declining R&D productivity, increased regulatory scrutiny and compliance requirements, pricing challenges, and recession threat. In this backdrop, India has attracted attention in the past decade and especially in the past five years, both as a producer and consumer of pharmaceutical products and services. Global companies are actively looking at India to increase efficiencies across the value chain from increasing market share, clinical development, manufacturing and IT outsourcing. Indigenous local pharma industry too has made its mark as one of the leading generics manufacturers of world.
| Programme Co-Chairs | ||
| Santhosh Francis Director – Sales Oracle Health Sciences Global Business Unit Oracle India |
Giridhar R K VP – Business Process Outsourcing Accenture |
Bala S Sr VP – Re-engineering Genpact |
The Indian market in itself is turning out to be an attractive market for the pharma companies with its growing and affluent domestic population. Indian Pharma market is estimated to reach USD 74 billion sales by 2020, according to a PricewaterhouseCoopers (PwC) report. Local pharma companies require open, industry-specific and standards-based information technology (IT) solutions to address unique opportunities and challenges to retain global competitive advantage. The impact of IT across the Pharmaceutical Value Chain will play an important role in helping to shape the competitiveness and future of Life Sciences industry.
EP News Bureau—Mumbai